In syngeneic mouse models of BRCA1‐deficient ovarian cancer and BRCA‐mutated TNBC cell lines, PARPi increases the infiltration of CD8+ T cells and NK cells in TME and upregulates PD‐L1 expression [14, 15, 16, 17]. The gene discussed is CD8A; the disease is ovarian cancer.